McKesson Stock Is a Triple Threat at New All-Time Highs. How to Trade It Here.

Barchart
Ouvrir sur Barchart
McKesson Stock Is a Triple Threat at New All-Time Highs. How to Trade It Here.
McKesson (MCK) combines robust momentum, solid profitability, and positive earnings revisions, but its valuation is pricey relative to modest growth. Shares are up nearly 30% over the past year. MCK maintains a 100% “Buy” technical opinion from Barchart. Setting a stop loss at the 100-day moving average may be prudent when buying at current levels.

Today’s Featured Stock

Valued at $127.6 billion, McKesson (MCK) operates primarily in the United States and Canada, serving retail pharmacies, hospitals, long-term care centers, clinics, and other healthcare institutions. McKesson’s operations are organized into four main segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.

What I’m Watching

I found today’s Chart of the Day by using Barchart’s powerful screening functions to sort for stocks with the highest technical buy signals and superior current momentum. I then used Barchart’s Flipcharts feature to review the charts for consistent price appreciation. MCK checks those boxes. The Trend Seeker issued a new “Buy” signal on Oct. 6. Since that signal, MCK is up 19.46%.

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

 

www.barchart.com

Barchart’s Technical Indicators for McKesson

Editor’s Note: The technical indicators below are updated live during the session every 20 minutes and can therefore change each day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report. These technical indicators form the Barchart Opinion on a particular stock.

McKesson hit an all-time high of $1,121.50 on Nov. 5.

McKesson has a Weighted Alpha of 38.87. MCK has a 100% “Buy” opinion from Barchart. The stock has gained 28.83% over the past 52 weeks. McKesson has its Trend Seeker “Buy” signal intact. The stock recently traded at $1,098.94 with a 50-day moving average of $963.23. MCK had 4 new highs and gained 9.65% in the last month. 60-month beta of 0.27. Relative Strength Index (RSI) is at 72.57. There’s a technical support level around $1,097.16.

Don’t Forget the Fundamentals

$127.6 billion market capitalization. 25.86x trailing price-earnings ratio. 0.34% dividend yield. Revenue is projected to grow 7.94% this year and another 6.87% next year. Earnings are estimated to increase 17.95% this year and an additional 13.30% next year.

Analyst and Investor Sentiment on McKesson

Wall Street analysts followed by Barchart give the stock 13 “Strong Buy” and 4 “Hold” opinions with price targets from $965 to $1,260. Value Line rates the stock “Highest” with price targets from $995 to $1,350. Morningstar thinks the stock is fairly valued. CFRA’s Market Scope rates the stock a “Hold" with a price target of $1,175. 42,230 investors are following the stock on Seeking Alpha, which rates it a “Hold.” TipRanks’ analysts have a consensus price target of $1,147.33. Short interest is 1.72% of the float with 2.90 days to cover.

The Bottom Line on McKesson

The company demonstrates robust momentum, solid profitability, and positive earnings revisions, but faces pressure from a pricey valuation and modest growth.

Value Line thinks this stock could go as high as $1,350 and short interest is only 1.72%.

If you buy at this level, a stop loss at the 100-day moving average might be prudent.

Additional disclosure: The Barchart Chart of the Day highlights stocks that are experiencing exceptional current price appreciation. They are not intended to be buy recommendations as these stocks are extremely volatile and speculative. Should you decide to add one of these stocks to your investment portfolio, it is highly suggested you follow a predetermined diversification and moving stop loss discipline that is consistent with your personal investment risk tolerance. 


On the date of publication, Jim Van Meerten did not directly have a position in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

McKesson Stock Is a Triple Threat at New All-Time Highs. How to Trade It Here. Ahead of Target Earnings, Here's What Barchart Data Says Comes Next for TGT Stock Dear Lowe’s Stock Fans, Mark Your Calendars for November 18 Dan Ives Says the Anthropic IPO Is a Crucial Moment for AI. I Still Think You Should Wait at Least a Quarter Before You Buy ANT Stock.